3 Stocks to Watch as Volume Picks Up: Coya Therapeutics (COYA), Cardiol Therapeutics (CRDL), Akari Therapeutics (AKTX)
Amid shifting market dynamics, the biotechnology industry is placing greater emphasis on performance alongside innovation. Companies are expected to translate scientific vision into structured, achievable outcomes while maintaining responsible use of capital. In this context, clear milestone planning, resilient clinical trial frameworks, and early regulatory interaction have emerged as essential drivers of sustainable development. Coya … Read more